Pharma-Bio Serv (Pharma-Bio Serv) Risk Assessment

View and export this data going back to 2006. Start your Free Trial

What is Pharma-Bio Serv Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Pharma-Bio Serv is: Moderate Risk: Sensitive, better choose undervalued stock.

Competitive Comparison of Pharma-Bio Serv's Risk Assessment

For the Health Information Services subindustry, Pharma-Bio Serv's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharma-Bio Serv's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pharma-Bio Serv's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Pharma-Bio Serv's Risk Assessment falls into.

Pharma-Bio Serv (OTCPK:PBSV) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Pharma-Bio Serv Risk Assessment Related Terms

Thank you for viewing the detailed overview of Pharma-Bio Serv's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma-Bio Serv (Pharma-Bio Serv) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pharma-Bio Serv Inc (OTCPK:PBSV) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 6 Road 696, Pharma-Bio Serv Building, Dorado, PRI, 00646

Website

https://www.pharmabioserv.com

Pharma-Bio Serv Inc is a compliance and technology transfer services consulting firm. It also provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. It has three reportable segments: Puerto Rico technical compliance consulting which is the key revenue driver; United States technical compliance consulting; and Europe technical compliance consulting. The company offers solutions to the pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies.

Executives

Elizabeth Plaza	10 percent owner	363 DORADO BEACH EAST, DORADO PR 00646
Altura Victor Sanchez	officer: President and CEO	C/O PHARMA-BIO SERV, INC., 6 ROAD 696, DORADO PR 00646
San Juan Holdings	10 percent owner	255 PONCE DE LEON, SUITE 305 MCS PLAZA, SAN JUAN PR 00917
Pedro J Lasanta	officer: Chief Financial Officer	373 MENDEZ VIGO, STE 110, DORADO PR 00646
Dov Perlysky	director	2 LAKESIDE DRIVE WEST, LAWRENCE NY 11559
L P Venturetek	10 percent owner	C/O DAVID SELENGUT ELLENOFF GROSSMAN, 370 LEXINGTON AVENUE 19TH FLOOR, NEW YORK NY 10017
Barron Partners Lp	10 percent owner	730 FIFTH AVENUE, 25TH FLOOR, NEW YORK NY 10019
Manuel O Morera	officer: Chief Financial Officer	373 MENDEZ VIGO, SUITE 110, DORADO PR 00646
Mark A Fazio	officer: Exec. Vice President and COO	P O BOX 1026 GREEN STREET, PERKASIE PA 18944
Kirk Wheeler Michel	director	209 EAST TRYON STREET, HILLSBOROUGH NC 27278
Irving L Wiesen	director	1273 NORTH AVENUE, APT 1E 7, NEW ROCHELLE NY 10804
Howard Spindel	director	39 BROADWAY SUITE 3300, NEW YORK NY 10028
Nelida Plaza Rodriguez	officer: Vice President and Secretary	G11 CALLE MADRE PERLA URB, DORADO DEL MAR, DORADO PR 00646
Krovim Llc	director, 10 percent owner, officer: Manager	P.O. BOX 339, LAWRENCE NY 11559